メインコンテンツにスキップ

Join us in celebrating Rare Disease Day 2021!

Developing treatments for rare diseases is a complex process. We’re committed to helping biotech and pharma fulfill the unmet needs that often accompany diseases affecting fewer than 1 in 2000 people.

Rare disease trials require special considerations for overall regulatory strategy, patient recruitment, data navigation, and market access to name a just few.  Certara’s experts use cutting edge biosimulation and regulatory science to help our partners get these critical medicines into the hands of patients who need them.


Check out these resources illustrating our extensive impact on Rare Disease Programs:

希少疾病と希少疾病用医薬品の開発

6MWTにおける変動性を理解する:DMD病態進行モデルの開発

FDAによる希少疾病用医薬品の承認を迅速化するには

The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access?

Powered by Translations.com GlobalLink OneLink Software